Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 340

1.

Understanding the Composition of a Successful Tweet in Urology.

Teoh JY, Mackenzie G, Smith M, Yuen SK, Gudaru K, Leow J, Leung CH, Ng CF, Loeb S.

Eur Urol Focus. 2019 Aug 27. pii: S2405-4569(19)30226-3. doi: 10.1016/j.euf.2019.08.008. [Epub ahead of print]

PMID:
31471219
2.

Increasing Social Media Use in Urology: 2017 American Urological Association Survey.

Loeb S, Carrick T, Frey C, Titus T.

Eur Urol Focus. 2019 Jul 24. pii: S2405-4569(19)30205-6. doi: 10.1016/j.euf.2019.07.004. [Epub ahead of print]

PMID:
31351900
3.

The Urology Care Foundation - trusted online resources in an era of misinformation.

Stork B, Loeb S.

Nat Rev Urol. 2019 Jul 12. doi: 10.1038/s41585-019-0215-1. [Epub ahead of print] No abstract available.

PMID:
31300752
4.

The Role of Deconstructive Teaching in the Training of Laparoscopy.

Balafoutas D, Joukhadar R, Kiesel M, Häusler S, Loeb S, Woeckel A, Herr D.

JSLS. 2019 Apr-Jun;23(2). pii: e2019.00020. doi: 10.4293/JSLS.2019.00020.

5.

Differing Views of Equity: How Prospective Educators Perceive Their Role in Closing Achievement Gaps.

Penner EK, Rochmes J, Liu J, Solanki SM, Loeb S.

RSF. 2019 Mar;5(3):103-127. doi: 10.7758/RSF.2019.5.3.06.

6.

Update on the Urology Tag Ontology: Standardized Hashtags for Social Media in Urology.

Loeb S, Katz MS, Stork B.

Eur Urol. 2019 Aug;76(2):261-264. doi: 10.1016/j.eururo.2019.05.014. Epub 2019 Jun 1. No abstract available.

PMID:
31164252
8.

Treatment of Metastatic Castration-resistant Prostate Cancer With Abiraterone and Enzalutamide Despite PSA Progression.

Becker DJ, Iyengar AD, Punekar SR, Ng J, Zaman A, Loeb S, Becker KD, Makarov D.

Anticancer Res. 2019 May;39(5):2467-2473. doi: 10.21873/anticanres.13366.

PMID:
31092441
9.

Overactive Surveillance: Is "Conservative" Management for Low-risk Prostate Cancer Too Aggressive?

Loeb S.

Eur Urol. 2019 Oct;76(4):467-468. doi: 10.1016/j.eururo.2019.04.003. Epub 2019 May 4. No abstract available.

PMID:
31060823
10.

Genomic Classifiers for Treatment Selection in Newly Diagnosed Prostate Cancer.

Fine ND, LaPolla F, Epstein M, Loeb S, Dani H.

BJU Int. 2019 May 4. doi: 10.1111/bju.14799. [Epub ahead of print] Review.

PMID:
31055874
11.

Twitter response to the 2018 US Preventive Services Task Force guidelines on prostate cancer screening.

Ke Y, Taylor J, Gao L, Wang H, Zhao H, Byrne N, Modgil V, Butaney M, Makarov DV, Prabhu V, Loeb S.

BJU Int. 2019 Sep;124(3):363-364. doi: 10.1111/bju.14734. Epub 2019 Mar 27. No abstract available.

PMID:
30811805
12.

Twitter-based Prostate Cancer Journal Club (#ProstateJC) Promotes Multidisciplinary Global Scientific Discussion and Research Dissemination.

Loeb S, Taylor J, Butaney M, Byrne NK, Gao L, Soule HR, Miyahira AK.

Eur Urol. 2019 May;75(5):881-882. doi: 10.1016/j.eururo.2019.01.025. Epub 2019 Jan 31. No abstract available.

PMID:
30711329
13.

Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.

van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, Brausi MA, Choyke PL, Cooperberg MR, Eggener S, Feller JF, Frauscher F, George AK, Hindley RG, Jenniskens SFM, Klotz L, Kovacs G, Lindner U, Loeb S, Margolis DJ, Marks LS, May S, Mcclure TD, Montironi R, Nour SG, Oto A, Polascik TJ, Rastinehad AR, De Reyke TM, Reijnen JS, de la Rosette JJMCH, Sedelaar JPM, Sperling DS, Walser EM, Ward JF, Villers A, Ghai S, Fütterer JJ.

World J Urol. 2019 Jan 22. doi: 10.1007/s00345-019-02636-7. [Epub ahead of print]

14.

Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer.

Drangsholt S, Walter D, Ciprut S, Lepor A, Sedlander E, Curnyn C, Loeb S, Malloy P, Winn AN, Makarov DV.

Urol Oncol. 2019 Feb;37(2):145-149. doi: 10.1016/j.urolonc.2018.11.022. Epub 2018 Dec 18.

PMID:
30578160
15.

Dissemination of Misinformative and Biased Information about Prostate Cancer on YouTube.

Loeb S, Sengupta S, Butaney M, Macaluso JN Jr, Czarniecki SW, Robbins R, Braithwaite RS, Gao L, Byrne N, Walter D, Langford A.

Eur Urol. 2019 Apr;75(4):564-567. doi: 10.1016/j.eururo.2018.10.056. Epub 2018 Nov 28.

PMID:
30502104
16.

The Intersection of Health and Education to Address School Readiness of All Children.

Peterson JW, Loeb S, Chamberlain LJ.

Pediatrics. 2018 Nov;142(5). pii: e20181126. doi: 10.1542/peds.2018-1126. Review.

PMID:
30366953
17.

Active Surveillance for Prostate Cancer.

Loeb S.

Rev Urol. 2018;20(2):101-103. doi: 10.3909/riu0802. No abstract available.

18.

Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance.

Loeb S, Folkvaljon Y, Bratt O, Robinson D, Stattin P.

J Urol. 2019 Feb;201(2):292-299. doi: 10.1016/j.juro.2018.09.042.

PMID:
30240688
19.

Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media.

Borgmann H, Cooperberg M, Murphy D, Loeb S, N'Dow J, Ribal MJ, Woo H, Rouprêt M, Winterbottom A, Wijburg C, Wirth M, Catto J, Kutikov A.

Eur Urol. 2018 Nov;74(5):644-650. doi: 10.1016/j.eururo.2018.08.022. Epub 2018 Sep 1. Review.

20.

Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.

Loeb S, Byrne N, Makarov DV, Lepor H, Walter D.

JAMA. 2018 Jun 5;319(21):2231-2233. doi: 10.1001/jama.2018.5616. No abstract available.

Supplemental Content

Loading ...
Support Center